Revvity (RVTY) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Revvity (RVTY) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn |
| 10 | Revvity | 12.81 Bn | 11.95 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -15.08% |
| Dec 28, 2025 | 106.47% |
| Sep 28, 2025 | -72.74% |
| Mar 30, 2025 | 67.94% |
| Dec 29, 2024 | 165.71% |
| Sep 29, 2024 | 83.61% |
| Jun 30, 2024 | -216.85% |
| Mar 31, 2024 | -130.76% |
| Oct 1, 2023 | -86.93% |
| Jul 2, 2023 | -106.78% |
| Apr 2, 2023 | 768.85% |
| Jan 1, 2023 | 67.75% |
| Oct 2, 2022 | 37.40% |
| Jul 3, 2022 | -34.07% |
| Apr 3, 2022 | -36.84% |
| Jan 2, 2022 | 18.95% |
| Oct 3, 2021 | 36.71% |
| Jul 4, 2021 | 368.67% |
| Apr 4, 2021 | 10.55% |
| Jan 3, 2021 | -15.04% |